DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 125 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $142,210 | -26.6% | 11,180 | -18.8% | 0.00% | -50.0% |
| Q2 2023 | $193,868 | -17.0% | 13,769 | -9.0% | 0.00% | 0.0% |
| Q1 2023 | $233,712 | +26.0% | 15,127 | +33.7% | 0.00% | 0.0% |
| Q4 2022 | $185,420 | -7.3% | 11,313 | +4.8% | 0.00% | 0.0% |
| Q3 2022 | $200,000 | +94.2% | 10,797 | -2.4% | 0.00% | +100.0% |
| Q1 2022 | $103,000 | -3.7% | 11,066 | +1.2% | 0.00% | 0.0% |
| Q4 2021 | $107,000 | -71.5% | 10,935 | -1.1% | 0.00% | -66.7% |
| Q3 2021 | $376,000 | -6.2% | 11,052 | +0.8% | 0.00% | 0.0% |
| Q2 2021 | $401,000 | -17.0% | 10,965 | +1.8% | 0.00% | -25.0% |
| Q1 2021 | $483,000 | -20.4% | 10,773 | +1.4% | 0.00% | -33.3% |
| Q4 2020 | $607,000 | +8.0% | 10,628 | -3.0% | 0.01% | 0.0% |
| Q3 2020 | $562,000 | +18.3% | 10,956 | +37.7% | 0.01% | -14.3% |
| Q2 2020 | $475,000 | +92.3% | 7,955 | +32.8% | 0.01% | +75.0% |
| Q1 2020 | $247,000 | – | 5,992 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $19,824,869 | 14.35% |
| Redmile Group, LLC | 3,593,317 | $58,894,466 | 2.41% |
| BRAIDWELL LP | 3,271,513 | $53,620,098 | 1.80% |
| Parkman Healthcare Partners LLC | 344,920 | $5,653,239 | 1.50% |
| ARMISTICE CAPITAL, LLC | 5,172,000 | $84,769,080 | 1.48% |
| Ikarian Capital, LLC | 367,119 | $6,017,081 | 1.45% |
| Sunesis Advisors, LLC | 96,299 | $1,578,341 | 1.01% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,349,228 | $38,503,847 | 0.80% |
| Hillsdale Investment Management Inc. | 328,200 | $5,379,198 | 0.46% |
| Avidity Partners Management LP | 1,126,000 | $18,455,140 | 0.40% |